Organ-on-a-Chip platform for pharmacogenetic predictions
Company 2020
Javelin Biotech, Woburn, USA
Javelin Biotech and Pfizer will work together on a platform to predict the pharmacokinetics of new drug candidates. They intend to study compounds for absorption, distribution, metabolism and excretion (ADME) using an organ-on-a-chip platform containing various human tissues (e.g. kidney, intestine, liver) and circulating culture media. The model will also be coupled to a computational algorithm that will translate the obtained data into a physiologically relevant model of human pharmacokinetics.
Javelin, Pfizer to develop organ-on-a-chip platform
info@javelinbio.com
Added on: 10-13-2020
[1] https://www.scienceboard.net/index.aspx?sec=ser&sub=def&pag=dis&ItemID=1398
